Sponsored Symposia

Sponsored Symposium by MSD
Why should SGLT-2 inhibitors be considered? beyond hitting a target

Chairperson: Chang Beom LEE (Hanyang University, Korea)
Jeong-Hyun PARK (Inje University, Korea)

Room 5 / 30 August 2019 (Fri)


Metabolic syndrome and SGLT2-I
Eun Young LEE (The Catholic University of Korea, Korea)

SGLT2i: mechanism of action and clinical evidence
Gregory FULCHER (University of Sydney, Australia)

New treatment option in SGLT2-I - ertugliflozin
So Hun KIM (Inha University, Korea)

Sponsored Symposium by Novo Nordisk
Obesity, pre-diabetes and CVD: time for a multifactorial approach

Chairperson: Hyun-Ho SHIN (Asan Chungmu Hospital, Korea)
Kyu Jeung AHN (Kyung Hee University, Korea)

Room 5 / 31 August 2019 (Sat)


The role of GLP-1 in weight management
Søren Kruse LILLEØRE (Novo Nordisk A/S, Denmark)

Can weight loss reverse type 2 diabetes?
Arne ASTRUP (University of Copenhagen, Denmark)

Comparison of cardiovascular outcome trials with GLP-1 analogues
Soo LIM (Seoul National University, Korea)